Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers

The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer

(2012) Fan Cheng et al.   Molecular Cancer

Cell proliferation of human ovarian cancer is regulated by the opioid growth factor-opioid growth factor receptor axis

(2009) Renee N. Donahue et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Dependence on Nuclear Localization Signals of the Opioid Growth Factor Receptor in the Regulation of Cell Proliferation

(2009) Fan Cheng et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Imiquimod Upregulates the Opioid Growth Factor Receptor to Inhibit Cell Proliferation Independent of Immune Function

(2008) Ian S. Zagon et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Alteration of cell-cycle regulation in epithelial ovarian cancer

(2008) E.J. NAM et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

The OGF–OGFr Axis Utilizes the p16INK4a and p21WAF1/CIP1 Pathways to Restrict Normal Cell Proliferation

(2008) Fan Cheng et al.   MOLECULAR BIOLOGY OF THE CELL

Expression of Opioid Growth Factor (OGF)–OGF Receptor (OGFr) Axis in Human Nonmedullary Thyroid Cancer

(2008) David Goldenberg et al.   THYROID